Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice modelAmanda Cano, María L. García, Antoni Camins et al.|Journal of Controlled Release|2019Cited by 330
Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: A new anti-seizure strategy for temporal lobe epilepsyAmanda Cano, María L. García, Miren Ettcheto et al.|Nanomedicine Nanotechnology Biology and Medicine|2018Cited by 92
Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 MiceMiren Ettcheto, Antoni Camins, Amanda Cano et al.|Molecular Neurobiology|2019Cited by 73
Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease DementiaMiren Ettcheto, Antoni Camins, Jordi Olloquequi et al.|Frontiers in Aging Neuroscience|2020Cited by 73
The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s DementiaJaume Folch, Antoni Camins, Jordi Olloquequi et al.|Frontiers in Aging Neuroscience|2019Cited by 71